Contact Screening for Healthcare Workers Exposed to Patients with COVID-19.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
05 12 2020
Historique:
received: 30 10 2020
revised: 24 11 2020
accepted: 01 12 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 16 12 2020
Statut: epublish

Résumé

In China and Italy, many cases of coronavirus disease 2019 (COVID-19) have occurred among healthcare workers (HCWs). Prompt identification, isolation and contact tracing of COVID-19 cases are key elements in controlling the COVID-19 pandemic. The aim of this study was to evaluate the rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection among HCWs exposed to patients with COVID-19 in relation to the main determinants of exposure. To assess the risk of exposure, we performed active symptom monitoring in 1006 HCWs identified as contacts of COVID19 cases. The presence of symptoms was statistically associated with a positive nasopharyngeal swab result. Only one subject was asymptomatic at the time of positive test. These data suggest that clinical history may help in the selection of subjects to be investigated by means of reverse transcriptase-polymerase chain reaction (RT-PCR) in the case of a shortage of diagnostic resources. We found that close contact (within 2 m for 15 min or more) was not statistically related to contagion. Regarding the use of personal protective equipment (PPE), only the use of facial masks was inversely related to the chance of becoming infected (

Identifiants

pubmed: 33291364
pii: ijerph17239082
doi: 10.3390/ijerph17239082
pmc: PMC7730521
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

JAMA. 2020 Apr 21;323(15):1439-1440
pubmed: 32163102
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Elife. 2020 May 11;9:
pubmed: 32392129
J Endocrinol Invest. 2020 Aug 27;:
pubmed: 32852704
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
J Infect. 2004 Oct;49(3):210-5
pubmed: 15337337
J Hosp Infect. 2020 May;105(1):100-101
pubmed: 32147406
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Clin Infect Dis. 2020 Nov 19;71(16):2218-2221
pubmed: 32179890
Int J Environ Res Public Health. 2020 Jul 15;17(14):
pubmed: 32679773
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930

Auteurs

Luca Coppeta (L)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

Giuseppina Somma (G)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

Lorenzo Ippoliti (L)

School of Occupational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.

Cristiana Ferrari (C)

School of Occupational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.

Iacopo D'Alessandro (I)

School of Occupational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.

Antonio Pietroiusti (A)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

Marco Trabucco Aurilio (M)

Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH